1Liu H,Jones BE,Bradham C,et al.Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-α.Am J Physiol Gastrointest Liver Physiol,2002,282:G257-G266.
2Li Z,Yang S,Lin H,et al.Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.Hepatology,2003,37:343-350.
3Feldstein AE,Werneburg NW,Canbay A,et al.Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal patyway.Hepatology,2004,40:185-194.
4Yuan M,Konstantopoulos N,Lee J,et al.Reversal of obesity-and dietinduced insulin resistance with salicylates or targeted disruption of Ikk.Science,2001,293:1673-1677.
5Feldstein A,Gores GJ.Steatohepatitis and apoptosis:therapeutic implications.Am J Gatroenterol,2004,99:1718-1719.
6Hotamisligil GS,Peraldi P,Budavari A,et al.IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance.Science,1996,271(5249):665-668.
7Hui JM,Hodge A,Farrell GC,et al.Beyond insulin resistance in NASH:TNF-α or adiponectin? Hepatology,2004,40:46-54.
8Castro CM,Erkelens DW,van Dijk H,et al.Free fatty acids:mediators of insulin resistance and atherosclerosis.Ned Tijdschr Geneskd,2002,146:103-109.
9Czaja MJ.Liver injury in the setting of steatosis:crosstalk between adipokine and cytokine.Hepatology,2004,40:19-21
10Reid RH,Sanyal AJ.Evaluation and management of non-alcoholic steatohepatitis.Eur J Gastroenterol Hepatol,2004,16:1117-1122.
